GGrantIndex
Sort

130,381 grants matching hiv

HIV-2 latency and its reversal

$887,215
Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2021 · AI

South African Medical Research Council Clinical Trials Unit (MRC CTU)

$887,214
Gita Ramjee · Medical Research Council Of South Africa · UM1 · FY2016 · AI

ADOLESCENT TRAJECTORIES FOR HOMELESSNESS &RISK FOR HIV

$887,189
University Of California Los Angeles · R01 · FY2002 · MH

Center for Structural Biology of HIV RNA

$887,161
Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2023 · AI

Chlamydial Immunity and Vaccine Development

$887,130
Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Pathogenomics of Chlamydial Infection

$887,130
Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Early neonatal treatment and immune quiescence

$887,055
Louise Kuhn · Columbia University Health Sciences · U01 · FY2015 · HD

Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques

$886,934
Koen K Van Rompay · Duke University · P01 · FY2020 · AI

Epigenetic HIV Silencing in Macrophages

$886,903
Ronald G Collman · University Of Pennsylvania · R61 · FY2017 · AI

A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection

$886,859
John A Moss · Oak Crest Institute Of Science · R01 · FY2024 · AI

Adherence Intervention for HIV + Alcohol Users

$886,858
Hunter College · R01 · FY2002 · AA

Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis

$886,780
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Interaction of HIV envelope with cell surface receptors

$886,780
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Production of Adenovector Based Vaccines

$886,735
Duncan L McVey · Genvec, Inc. · R44 · FY2010 · AI

HIV-2 latency and its reversal

$886,729
Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2023 · AI

Inflammation

$886,728
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Rationally Designed Pan-Ebolavirus Vaccine

$886,705
M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2021 · AI

Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle

$886,634
Markella V. Zanni · Massachusetts General Hospital · R01 · FY2019 · HL

Quintiles Clinical Trial Unit for HIV/AIDS Clinical Trials Networks

$886,623
Kathleen E. Squires · Quintiles Federated Services, Inc. · U01 · FY2009 · AI

Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine

$886,533
Frederick Lewis Altice · Yale University · R01 · FY2016 · DA

Persistent modulation of microbiota to enhance HIV vaccination

$886,454
Nichole Rose Klatt · University Of Washington · R01 · FY2016 · AI